Rosty Raykov

All filings by Rosty Raykov on record concern Fennec Pharmaceuticals Inc. Over a trading history stretching from 28 December 2022 to 1 September 2026, the count stands at 60 filings.

Market trades split into 1 purchase and 21 sales (€1.6M). The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 26 share grants and 10 option exercises. 2026 to date brings no purchases and 4 sales.

The newest entry dates from 1 September 2026: a share grant, in Fennec Pharmaceuticals Inc. The latest purchase dates back some time: it was published 928 days ago, on 3 April 2024. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.